Association of candidate genetic variants with restless legs syndrome in end stage renal disease: A multicenter case-control study in Taiwan

European Journal of Neurology

Volumn 21, Issue 3, 2014, Pages 492-498

  Lin, C H ^a   Chen, M L ^b   Wu, V C ^a   Li, W Y ^a   Sy, H N ^c   Wu, S L ^c   Chang, C C ^c   Chiu, P F ^c   Liou, H H ^d   Lin, C Y ^e   Chang, H W ^f   Lin, S Y ^a   Wu, K D ^a   Chen, Y M ^a   Wu, R M ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d Hsin Jen Hospital   (Taiwan)

^e EN CHU KONG HOSPITAL   (Taiwan)

^f Far Eastern Polyclinic   (Taiwan)

Author keywords

BTBD9; End stage renal disease; MAP2K5; MEIS1; PTPRD; Restless legs syndrome

Indexed keywords

BTBD9; END STAGE RENAL DISEASE; MAP2K5; MEIS1; PTPRD; RESTLESS LEGS SYNDROME;

AGED; CHROMOSOMES, HUMAN, PAIR 2; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GENOTYPE; HUMANS; KIDNEY FAILURE, CHRONIC; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; RECEPTORS, PROGESTERONE; RESTLESS LEGS SYNDROME; RETROSPECTIVE STUDIES; TAIWAN;

EID: 84893861016     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12337     Document Type: Article

References (25)

1. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101-109.
2. Bhalsing K, Suresh K, Muthane UB, Pal PK. Prevalence and profile of restless legs syndrome in Parkinson's disease and other neurodegenerative disorders: a case-control study. Parkinsonism Relat Disord 2013; 19: 426-430.
3. Rangarajan S, D'Souza GA. Restless legs syndrome in Indian patients having iron deficiency anemia in a tertiary care hospital. Sleep Med 2007; 8: 247-251.
4. Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 1996; 28: 372-378.
5. La Manna G, Pizza F, Persici E, et al. Restless legs syndrome enhances cardiovascular risk and mortality in patients with end-stage kidney disease undergoing long-term haemodialysis treatment. Nephrol Dial Transplant 2011; 26: 1976-1983.
6. Trenkwalder C, Paulus W. Restless legs syndrome: pathophysiology, clinical presentation and management. Nat Rev Neurol 2010; 6: 337-346.
7. Araujo SM, de Bruin VM, Nepomuceno LA, et al. Restless legs syndrome in end-stage renal disease: clinical characteristics and associated comorbidities. Sleep Med 2010; 11: 785-790.
8. Lin CH, Wu VC, Li WY, et al. Restless legs syndrome in end-stage renal disease: a multicenter study in Taiwan. Eur J Neurol 2013; 20: 1025-1031.
9. Schormair B, Kemlink D, Roeske D, et al. PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome. Nat Genet 2008; 40: 946-948.
10. Stefansson H, Rye DB, Hicks A, et al. A genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007; 357: 639-647.
11. Winkelmann J, Schormair B, Lichtner P, et al. Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007; 39: 1000-1006.
12. Winkelmann J, Czamara D, Schormair B, et al. Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1. PLoS Genet 2011; 7: e1002171.
13. Schormair B, Plag J, Kaffe M, et al. MEIS1 and BTBD9: genetic association with restless leg syndrome in end stage renal disease. J Med Genet 2011; 48: 462-466.
14. Chen NH, Chuang LP, Yang CT, et al. The prevalence of restless legs syndrome in Taiwanese adults. Psychiatry Clin Neurosci 2010; 64: 170-178.
15. Kuo HW, Tsai SS, Tiao MM, Liu YC, Lee IM, Yang CY. Analgesic use and the risk for progression of chronic kidney disease. Pharmacoepidemiol Drug Saf 2010; 19: 745-751.
16. The United States Renal Disease System System 2007. Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases, 2007. http://www.usrds.org/atlas07.aspx
17. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003; 4: 121-132.
18. Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 2006; 10: 153-167.
19. Foulkes AS. Applied Statistical Genetics with R: For Population-Based Association Studies. Springer Science+Business Media: New York, NY, 2009.
20. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006; 38: 209-213.
21. Yang WC, Hwang SJ. Incidence, prevalence and mortality trends of dialysis end-stage renal disease in Taiwan from 1990 to 2001: the impact of national health insurance. Nephrol Dial Transplant 2008; 23: 3977-3982.
22. Xiong L, Catoire H, Dion P, et al. MEIS1 intronic risk haplotype associated with restless legs syndrome affects its mRNA and protein expression levels. Hum Mol Genet 2009; 18: 1065-1074.
23. DeAndrade MP, Johnson RL Jr, Unger EL, et al. Motor restlessness, sleep disturbances, thermal sensory alterations and elevated serum iron levels in Btbd9 mutant mice. Hum Mol Genet 2012; 21: 3984-3992.
24. Freeman A, Pranski E, Miller RD, et al. Sleep fragmentation and motor restlessness in a Drosophila model of restless legs syndrome. Curr Biol 2012; 22: 1142-1148.
25. Merlino G, Lorenzut S, Gigli GL, et al. A case-control study on restless legs syndrome in nondialyzed patients with chronic renal failure. Mov Disord 2010; 25: 1019-1025.